NeuronUP slows cognitive decline in patients with Alzheimer’s disease

José Antonio Silva, speech therapist specialized in neurological damage, has been awarded by the Cátedra Fundación Eurocaja Rural-UCLM, as author of the best Bachelor’s Thesis for ‘Effectiveness of a cognitive stimulation program using NeuronUP in patients with Alzheimer’s disease’. Following the research conducted, Silva’s work, concludes that treatment with the NeuronUP web platform applied to these people with Alzheimer’s has been effective, allowing a slowing of that decline during the established sessions and serving as a basis for future research.

Research on Alzheimer’s Disease

Since the start of his career, he has researched this disease, presenting various papers at national conferences such as the Spanish Society for Neuroscience (SENC) or the Young Researchers of Albacete (AJIAB).

His grandmother’s illness as motivation to develop research on cognitive decline in Alzheimer’s disease

Marked by his childhood and his grandmother’s experience, who suffered the disease for fifteen years, José Antonio Silva decided to begin a study to verify the use of the NeuronUP web platform as a tool for the slowing of cognitive decline in people with Alzheimer’s disease.

Cognitive stimulation as a means to halt cognitive decline

Aware that this is a neurodegenerative pathology that has neither a cure nor an effective drug, he has observed that cognitive stimulation with the activities proposed by this platform allows for an ideal intervention. The young man completed his degree at the Facultad de Ciencias de la Salud de Talavera de la Reina, at the Universidad de Castilla-La Mancha, supervised by Professor Juan José Criado.

Silva states that Alzheimer’s Disease (AD) is the most common of all dementias, representing two-thirds of all cases. This type of dementia produces a progressive dismantling of all higher cognitive functions, among which is language. Furthermore, the use of information technologies could be a protective factor against cognitive decline, since interventions carried out through web-based neurorehabilitation platforms succeed in reducing this deterioration.

Study on the use of NeuronUP to slow cognitive decline in people with Alzheimer’s

A total of 41 subjects participated in the study (control group and experimental group). First, an assessment of semantic verbal fluency was carried out, as well as naming for both groups. Subsequently, a cognitive neurorehabilitation treatment using NeuronUP was applied to the group with AD.

Conclusions

As a result, it was observed that there are statistically significant differences between both groups, in both fluency and naming tasks, likewise differences appear in the pre- and post-measures of the experimental group after applying the treatment, without any cognitive worsening.

The study by this native of Jerez has not gone unnoticed and has received recognition from professors, experts in the field and associations such as la Fundación Rural-UCLM, which awards these works and whose objective is to recognize academic quality and the impact of the topic addressed on economic and social development.

Currently, José Antonio Silva, born in Jerez, is working at the speech therapy clinic ‘M. Chueca Logopedia’, in Jerez and, in addition, at a state-assisted school called Jesús María la Asunción, where he carries out what he is most passionate about: addressing the speech, voice, language, communication and swallowing difficulties of all those who need it.

If you liked this article about the effectiveness of NeuronUP to slow the cognitive decline decline in people with Alzheimer’s, you may also be interested in:

“This article has been translated. Link to the original article in Spanish:”
NeuronUP ralentiza el deterioro cognitivo en pacientes con Alzheimer